This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Jan 21;340(3):197-206.

doi: 10.1056/NEJM199901213400306.

Treatment of asthma with drugs modifying the leukotriene pathway

J M Drazen¹, E Israel, P M O'Byrne

Affiliations

PMID: 9895400
DOI: 10.1056/NEJM199901213400306

Review

Treatment of asthma with drugs modifying the leukotriene pathway

J M Drazen et al. N Engl J Med. 1999.

. 1999 Jan 21;340(3):197-206.

doi: 10.1056/NEJM199901213400306.

Authors

J M Drazen¹, E Israel, P M O'Byrne

Affiliation

¹ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

PMID: 9895400
DOI: 10.1056/NEJM199901213400306

Erratum in

N Engl J Med 1999 Feb 25;340(8):663
N Engl J Med 1999 Nov 18;341(21):1632

No abstract available

PubMed Disclaimer

Similar articles

Leukotrienes in respiratory disease.
McMillan RM. McMillan RM. Paediatr Respir Rev. 2001 Sep;2(3):238-44. doi: 10.1053/prrv.2001.0146. Paediatr Respir Rev. 2001. PMID: 12052325 Review.
Leukotriene modifiers for asthma treatment.
Montuschi P, Peters-Golden ML. Montuschi P, et al. Clin Exp Allergy. 2010 Dec;40(12):1732-41. doi: 10.1111/j.1365-2222.2010.03630.x. Clin Exp Allergy. 2010. PMID: 21059119 Review.
[Antileukotrienes in the therapy of bronchial asthma].
Rossi G. Rossi G. Recenti Prog Med. 1998 Dec;89(12):654-6. Recenti Prog Med. 1998. PMID: 9951316 Review. Italian. No abstract available.
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P, Baccard N, Advenier C. Devillier P, et al. Pharmacol Res. 1999 Jul;40(1):3-13. doi: 10.1006/phrs.1998.0458. Pharmacol Res. 1999. PMID: 10378985 Review.
Current treatment of asthma--focus on leukotrienes.
Crowther SD, Rees PJ. Crowther SD, et al. Expert Opin Pharmacother. 2000 Jul;1(5):1021-40. doi: 10.1517/14656566.1.5.1021. Expert Opin Pharmacother. 2000. PMID: 11249493 Review.

See all similar articles

Cited by

Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study.
Kim SW, Kim H, Ryu YJ, Lee JH, Shim SS, Kim YK, Chang JH. Kim SW, et al. Open Respir Med J. 2016 Jun 30;10:36-45. doi: 10.2174/1874306401610010036. eCollection 2016. Open Respir Med J. 2016. PMID: 27499820 Free PMC article.
Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations.
Lundström SL, Saluja R, Adner M, Haeggström JZ, Nilsson G, Wheelock CE. Lundström SL, et al. J Lipid Res. 2013 Jan;54(1):116-26. doi: 10.1194/jlr.M030171. Epub 2012 Oct 3. J Lipid Res. 2013. PMID: 23034214 Free PMC article.
Mechanistic insight on the role of leukotriene receptors in ischemic-reperfusion injury.
Khan H, Gupta A, Singh TG, Kaur A. Khan H, et al. Pharmacol Rep. 2021 Oct;73(5):1240-1254. doi: 10.1007/s43440-021-00258-8. Epub 2021 Apr 5. Pharmacol Rep. 2021. PMID: 33818747 Review.
Genetic effect of CysLTR2 polymorphisms on its mRNA synthesis and stabilization.
Shin JA, Chang HS, Park SM, Jang AS, Park SW, Park JS, Uh ST, Il Lim G, Rhim T, Kim MK, Choi IS, Chung IY, Park BL, Shin HD, Park CS. Shin JA, et al. BMC Med Genet. 2009 Oct 20;10:106. doi: 10.1186/1471-2350-10-106. BMC Med Genet. 2009. PMID: 19840403 Free PMC article.
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.
Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP 3rd. Selman M, et al. Drugs. 2004;64(4):405-30. doi: 10.2165/00003495-200464040-00005. Drugs. 2004. PMID: 14969575 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information